128 related articles for article (PubMed ID: 2561736)
1. Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diester.
Gorsky LD; Cross SM; Morin MJ
Cancer Commun; 1989; 1(2):83-92. PubMed ID: 2561736
[TBL] [Abstract][Full Text] [Related]
2. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
3. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
Constantinou A; Henning-Chubb C; Huberman E
Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells.
Cardellini E; Durban E
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):303-7. PubMed ID: 8385936
[TBL] [Abstract][Full Text] [Related]
5. Phorbol diester-induced alterations in the expression of protein kinase C isozymes and their mRNAs. Analysis in wild-type and phorbol diester-resistant HL-60 cell clones.
McSwine-Kennick RL; McKeegan EM; Johnson MD; Morin MJ
J Biol Chem; 1991 Aug; 266(23):15135-43. PubMed ID: 1714454
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
7. Phorbol regulation of topoisomerases I and II in human leukemia cells. Studies in an additional cell pair sensitive or resistant to phorbol-induced differentiation.
Ellis AL; Altschuler E; Bales E; Hinds M; Mayes J; Soares L; Zipf TF; Zwelling LA
Biochem Pharmacol; 1994 Jan; 47(2):387-96. PubMed ID: 8304982
[TBL] [Abstract][Full Text] [Related]
8. Effect of bryostatin 1 on drug-induced, topoisomerase II-mediated DNA cleavage and topoisomerase II gene expression in human leukemia cells.
Zwelling LA; Chan D; Altschuler E; Mayes J; Hinds J; Pettit GR
Biochem Pharmacol; 1991 Mar; 41(5):829-32. PubMed ID: 1847817
[TBL] [Abstract][Full Text] [Related]
9. Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells.
Ellis AL; Zwelling LA
Biochem Pharmacol; 1994 Nov; 48(9):1842-5. PubMed ID: 7980655
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
Chresta CM; Hall BF; Francis GE
Leukemia; 1995 Aug; 9(8):1373-81. PubMed ID: 7643627
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Bertrand R; Solary E; Jenkins J; Pommier Y
Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
[TBL] [Abstract][Full Text] [Related]
12. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
Lelièvre S; Benchokroun Y; Larsen AK
Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.
Fraser DJ; Brandt TL; Kroll DJ
Mol Pharmacol; 1995 Apr; 47(4):696-706. PubMed ID: 7723730
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells.
Sahyoun N; Wolf M; Besterman J; Hsieh T; Sander M; LeVine H; Chang KJ; Cuatrecasas P
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1603-7. PubMed ID: 3006058
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
Zwelling LA; Hinds M; Chan D; Altschuler E; Mayes J; Zipf TF
Cancer Res; 1990 Nov; 50(22):7116-22. PubMed ID: 2171756
[TBL] [Abstract][Full Text] [Related]
16. The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Altschuler E; Mayes J; Hinds M; Chan D
Cancer Chemother Pharmacol; 1991; 29(1):48-52. PubMed ID: 1660353
[TBL] [Abstract][Full Text] [Related]
17. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
Constantinou AI; Vaughan AT; Yamasaki H; Kamath N
Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591
[TBL] [Abstract][Full Text] [Related]
18. Modulation of topoisomerase activities by tumor necrosis factor.
Baloch Z; Cohen S; Fresa K; Coffman FD
Cell Immunol; 1995 Jan; 160(1):98-103. PubMed ID: 7842491
[TBL] [Abstract][Full Text] [Related]
19. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
[TBL] [Abstract][Full Text] [Related]
20. Regulation of topoisomerase I and II activities by cyclic nucleotide- and phospholipid-dependent protein kinases. Effects of interactions between the two transduction pathways.
Mattern MR; Nambi P; Bartus JO; Mirabelli CK; Crooke ST; Johnson RK
Receptor; 1991; 1(3):181-90. PubMed ID: 1668830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
